Frontline compliance requires expert juggling
Posted on 04-18-2019 by Lisa Thompson

There’s no room for clowning about when it comes to risk management and maintaining the integrity of international business. According to records of ancient Chinese history, the armies of the Chu and Song states were facing each other in readiness for battle in 630 BC when a Chu warrior, Xiong... Read More

Enter the ninja: A disciplined approach to defeat regulatory risk
Posted on 12-05-2018 by Lisa Thompson

Forget about the turtles. Today is International Ninja Day, but what we’re on about has more to do with regulatory risk than teenagers or (as far as we know) mutants. Why does International Ninja Day make us think ‘compliance program’? International Ninja Day was the brainchild of... Read More

A new No. 1: Petrobras agrees to biggest FCPA settlement
Posted on 10-05-2018 by Lisa Thompson

Petrobras has reached a $1.78 billion settlement with the DOJ and SEC over bribes to politicians and political parties in Brazil. This is the first time an enforcement action over FCPA violations has exceeded a billion dollars. The amount is bigger than the nearest two settlements combined, and the case... Read More

Compliance risk in the UK: what companies need to know
Posted on 08-29-2018 by Lisa Thompson

The global compliance landscape is becoming ever more complex, and some of the most significant recent developments in ABC and AML legislation have happened in the UK. All companies who operate in the UK need to be aware of these laws, as well as growing consumer expectations of ethical behavior, if... Read More

Danske Bank and Siemens invite ABC compliance in the boardroom
Posted on 08-16-2018 by Lisa Thompson

Danske Bank and Siemens have appointed chief compliance officers to their boards of directors this summer. We explore why compliance has become accepted as a critical function in any company. At the next board meeting of Denmark’s biggest bank, a chief compliance officer will be at... Read More

Why Pharma & Biomed Companies’ Risk Analysis Processes are Due for a Check-Up
Posted on 07-18-2018 by Lisa Thompson

Just three years ago, Teva Pharmaceuticals, a drug-maker in Israel, disclosed to both the U.S. Securities & Exchange Commission and the U.S. Department of Justice that an on-going internal probe had revealed possible violations of the Foreign Corrupt Practices Act (FCPA) and/or local laws. Ultimately... Read More

Regulatory Risk in the U.S.: What Companies Need to Know
Posted on 04-27-2018 by Lisa Thompson

Since its introduction of the Foreign Corrupt Practices Act (FCPA) in 1977, the United States has led the world in efforts to counter bribery and corruption in corporate business that traverses national borders. Now it has gone a full step further with permanent adoption and expansion of its Corporate... Read More